NCT00293761View on ClinicalTrials.gov

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Open-angle GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost, Investigational

One drop in study eye once daily for 13 days

DRUG

Travoprost (TRAVATAN)

One drop in study eye once daily for 13 days

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY